Trading
Ideas
Buy Indicators
Top Buy Stocks
Popular
Pivot Bottom
Double Bottom
Golden Star
Short-term
Unlock
Golden Star
Long-term
Golden Cross
Possible Runners
Rising Trends
All Lists
Sell Indicators
Top Sell Stocks
Pivot Top
Double Top
Death Star
Short-term
Unlock
Death Star
Long-term
Death Cross
Falling Trends
All Lists
Dividends
Highest Yield
Kings
Aristocrats
Other
RSI Oversold
Top Performers
Undervalued
Popular
Tools
Research Tools
My Watchlists
Popular
My Portfolios
Beta!
Screener
AI Analyst
Popular
Heatmap
Predictions
Smart Portfolios
Calendars
Earnings Calendar
Dividend Calendar
Other
U.S. Congress Trades
Interest Calculator
Commodities
Top Online Brokers
Exchanges
News
All News
Stock Market News
Guides
Analysis & Ideas
Top Buy Stocks
Pricing & Plans
Meet
AI Analyst
Sign In
Sign in with Facebook
Sign in with Apple
or
Forgot password?
Remember me
Sign In
Creating an account or logging in means you agree to StockInvest.us
Terms of Use
and
Privacy Policy
.
See Today's Golden Star Stocks 🔥 Free for 7 Days
See Today's Golden Star Stocks 🔥 Free for 7 Days
Sign In / Sign Up
Sign In
Sign in with Facebook
Sign in with Apple
or
Forgot password?
Remember me
Sign In
Creating an account or logging in means you agree to StockInvest.us
Terms of Use
and
Privacy Policy
.
Don't have an account?
Sign Up Here
Pricing & Plans
IHE Analysis
Chart & Forecast
Dividends
Data & Signals
Historical Prices
Predictions
News
Top Buy Stocks
Golden Star
Short-term
Unlock
Golden Star
Long-term
Trading Ideas
Buy Indicators
Top Buy Stocks
Popular
Pivot Bottom
Double Bottom
Golden Star
Short-term
Unlock
Golden Star
Long-term
Possible Runners
All Lists
Sell Indicators
Top Sell Stocks
Pivot Top
Double Top
Death Star
Short-term
Unlock
Death Star
Long-term
All Lists
Dividends
Highest Yield
Kings
Aristocrats
Other
RSI Oversold
Top Performers
Undervalued
Popular
All Lists
Tools
Research Tools
My Watchlists
Popular
Screener
AI Analyst
Popular
Predictions
Prediction Hub
Results
Top Predicted Movers
Tutorial
Heatmap
Smart Portfolios
Calendars
Earnings Calendar
Dividend Calendar
Other
Interest Calculator
U.S. Congress Trades
Commodities
Top Online Brokers
News Digest
Exchanges
×
Success!
NYSEARCA:
IHE
Ishares Us Pharmaceuticals Etf ETF News
Financial Services
>
Asset Management
Buy IHE
*Your capital is at risk
$90.02
+1.03 (+1.16%)
At Close:
Jun 03, 2026
Forecast
Dividends
Signals
Historical Prices
Predictions
News
11 Favored High-Yield Firms Within The Dow For 2017
12:00am, Thursday, 26'th Jan 2017
Read more
What Lies Ahead for Pharma ETFs?
12:00am, Thursday, 19'th Jan 2017
Read more
When Staring At A Divergence
12:00am, Thursday, 12'th Jan 2017
Read more
For Those Feeling Left Behind
12:00am, Monday, 09'th Jan 2017
Read more
Last Night's Election - A Series Of Fortunate Events For Big Pharma
12:00am, Wednesday, 09'th Nov 2016
Read more
Stocks Heading Toward A Healthy Cleanse
12:00am, Friday, 14'th Oct 2016
Read more
Looking For ETF Dogs That Will Hunt
12:00am, Monday, 10'th Oct 2016
Read more
Valeant's Regulatory Nightmare
12:00am, Sunday, 02'nd Oct 2016
Read more
Getting Into The Drug Business: From NDAs To PDUFA Dates
06:20pm, Tuesday, 27'th Sep 2016
Read more
Pharmaceutical Policy Under Clinton
12:00am, Monday, 19'th Sep 2016
Read more
Will Defensive Sectors Be Defensive This Business Cycle?
12:00am, Wednesday, 03'rd Aug 2016
Read more
Government Study: Cellphone Radiation Linked To Cancer
12:00am, Friday, 27'th May 2016
Read more
Concordia: Climbing Away From Valeant
12:00am, Thursday, 25'th Feb 2016
Read more
ETF Week Ahead Preview: Hoping For No November Rain
12:00am, Monday, 02'nd Nov 2015
Read more
These ETFs Should Love The Pfizer-Allergan News
12:00am, Thursday, 29'th Oct 2015
Read more
«
1
2
...
11
12
13
14
15
16
17
18
19
20
»
Click
to get the best stock tips daily for free!
Top Fintech Company
featured in
The Global Fintech Index 2020
as the top Fintech company of the country.
Full report by
YOU ARE SIGNED OUT
Sign in with Facebook
Sign in with Apple
or
Continue with Email
By continuing, you agree to StockInvest.us
Terms of Service
and acknowledge that you’ve read our
Disclaimer
&
Privacy Policy
.